Company profile

RadNet

Medical Imaging & Radiology

Company profile

About RadNet

RadNet is the largest provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States, operating 440 imaging centers across 11 states as of May 2026. The company employs approximately 11,000 staff members, including more than 1,000 radiologists, and performs over 11 million procedures annually. RadNet's comprehensive service portfolio spans from X-ray to interventional radiology, serving patients, providers, and payors with a focus on quality, access, and value. Through DeepHealth, its digital health division based in Somerville, Massachusetts, RadNet has developed an extensive AI software portfolio focused on cancer screening for the three most prevalent cancers: breast, lung, and prostate. The company also leverages AI technology in neuroradiology for diseases like Alzheimer's, and in operational processes such as patient outreach and engagement. RadNet's AI approach aims to enable large-scale population health screening programs while improving accuracy and reducing costs. RadNet's technology division, eRAD, provides integrated, web-based, cloud-based solutions for medical imaging workflow, including RIS, PACS, speech recognition, and patient and physician portals. These solutions serve over 500 hospitals, teleradiology companies, imaging centers, ACOs, and physician groups. The company operates specialty centers of excellence in breast health (Breastlink) and prostate health, offering advanced imaging modalities and multi-disciplinary care. RadNet has been recognized as a Top 100 Most Innovative Company by Information Week and voted "Most Wired" imaging company by Imaging Technology News.

Company description RadNet official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at RadNet?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Alzheimer's disease
  • Breast cancer
  • General diagnostic imaging conditions
  • Lung cancer
  • Prostate cancer

Who it serves

  • ACOs
  • Health Systems
  • Hospitals
  • Individual Patients
  • Large Employer Groups
  • Payers
  • Physician Groups
  • Teleradiology Companies

Deployment & integration

Cloud Saas deployment with recorded integration context.

Recorded integration context: DICOM gateways, EHR-certified (2014 certification), Health Information Exchanges (HIE), Multiple insurance plan integrations.

Geographic context

MarketsUnited States (California, New York, New Jersey, Florida, Delaware, Maryland, Arizona, Texas, Virginia, Indiana, Idaho)
Company sourceOfficial website

Company milestones

Platform expansion

440 imaging centers as of May 10, 2026; 11,000+ employees; 1,000+ radiologists as of December 31, 2025; Expansion of AI portfolio through DeepHealth division

Partnerships

Recorded partners

  • 500+ hospitals, teleradiology companies, imaging centers, ACOs, and physician groups use eRAD solutions
  • Multiple Health Information Exchanges
  • State of New Jersey HIE consulting partnership

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

DeepHealth AI Portfolio

Comprehensive AI software solutions for cancer screening in breast, lung, prostate, and brain imaging

Software · Cloud SaaSCompany source

eRAD PACS

Vendor-neutral, web-based Picture Archiving and Communication System with global worklist

Software · Cloud SaaSCompany source

eRAD Patient & Physician Portals

Web-based portals providing real-time access to imaging reports and results

Platform · Cloud SaaSCompany source

eRAD RIS

2014 EHR-certified Radiology Information System with integrated workflow automation

Software · Cloud SaaSCompany source

eRAD Speech Recognition

Integrated speech recognition for radiology reporting workflow

Software · Cloud SaaSCompany source

RADAR Clinical Communication Tool

Real-time clinical notification system delivering critical results via text, voice, email, and IM

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study - Study protocol.

Clinical and translational radiation oncology · Sep 1, 2026

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

34% reduction in breast cancer death rates in U.S. since 1990

Breast disease management outcomes

99.2% five-year survival rate for prostate cancer

Prostate health outcomes

Up to 40% cost savings vs hospital-based imaging

Outpatient imaging value proposition

Twice as many procedures as next two providers combined

Market leadership - 11+ million procedures annually

500+ hospitals, teleradiology companies, imaging centers, ACOs, and physician groups

Medical imaging workflow automation and clinical communication

Reduced operating costs, higher patient satisfaction, and better clinical communication for 500+ organizations

State of New Jersey

Statewide Health Information Exchange (HIE) consulting and participation

eRAD participates with multiple Health Information Exchanges and is consulting with the state of New Jersey to assist with its statewide HIE

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Howard Berger

President and Chief Executive Officer

06 · Company updates

Updates from RadNet

Recent articles published on RadNet's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon